Depression in MS: Is brain imaging helpful?



Similar documents
Depression. Maria Pia Amato

A Depression Education Toolkit

Depression Flow Chart

Recognition and Treatment of Depression in Parkinson s Disease

Donna Graves, M.D. Assistant Professor University of Texas Southwestern Multiple Sclerosis Clinic

Elizabeth A. Crocco, MD Assistant Clinical Professor Chief, Division of Geriatric Psychiatry Department of Psychiatry and Behavioral Sciences Miller

Recognizing and Treating Depression in Children and Adolescents.

Mental health issues in the elderly. January 28th 2008 Presented by Éric R. Thériault

TEEN MARIJUANA USE WORSENS DEPRESSION

Mental health problems in people with MS: What can we do? Eli Silber Consultant Neurologist Kings College hospital

Depre r s e sio i n o i n i a dults Yousuf Al Farsi

ADHD AND ANXIETY AND DEPRESSION AN OVERVIEW

Depression & Multiple Sclerosis. Managing Specific Issues

Depression & Multiple Sclerosis

Major Depressive Disorder (MDD) Guideline Diagnostic Nomenclature for Clinical Depressive Conditions

Depression Assessment & Treatment

INDEX. and side effects of light therapy, 73 Bulimia nervosa See Eating disorders Bupropion, in treatment of SAD, 91

Update on guidelines on biological treatment of depressive disorder. Dr. Henry CHEUNG Psychiatrist in private practice

MOLINA HEALTHCARE OF CALIFORNIA

When You Are More Than Down in the Dumps Depression in Older Adults

Neurobiology of Depression in Relation to ECT. PJ Cowen Department of Psychiatry, University of Oxford

Diseases of the Nervous System. Neal G. Simon, Ph.D. Professor, Dept of Biological Sciences Lehigh University

Feeling Moody? Major Depressive. Disorder. Is it just a bad mood or is it a disorder? Mood Disorders. S Eclairer

Mellen Center Approaches: Identifying and managing depression in MS

Depression: What You Need to Know

Presently, there are no means of preventing bipolar disorder. However, there are ways of preventing future episodes: 1

Clinical Practice Guideline: Depression in Primary Care, Adult 4 Taft Court Rockville, MD

Major Depression. What is major depression?

Care Manager Resources: Common Questions & Answers about Treatments for Depression

Talking about Depression and Other Emotional Changes

OHTAC Recommendation

Multiple Sclerosis Society of Canada. CADA Presentation May 4, 2011

MAJOR DEPRESSION DURING CONCEPTION AND PREGNANCY: A Guide for Patients and Families

Multiple Sclerosis: An imaging review and update on new treatments.

MOOD DISORDERS AND EPILEPSY

Part 1: Depression Screening in Primary Care

Depression and its Treatment in Older Adults. Gregory A. Hinrichsen, Ph.D. Geropsychologist New York City

Alfredo Velez, M.D. ECT: A REVIEW

Chapter 10. Summary & Future perspectives

MULTIMODAL THERAPY FOR MS- ASSOCIATED COGNITIVE DYSFUNCTION

Obsessive Compulsive Disorder: a pharmacological treatment approach

Post Stroke Depression: Screening and Assessment Tools

Depression is a medical illness that causes a persistent feeling of sadness and loss of interest. Depression can cause physical symptoms, too.

Depression Screening in Primary Care

Depression, Mental Health and Native American Youth

CHAPTER 5 MENTAL, BEHAVIOR AND NEURODEVELOPMENT DISORDERS (F01-F99) March MVP Health Care, Inc.

What is PD? Dr Catherine Dotchin MD MRCP Consultant Geriatrician

The Role of Neuropsychology in the Treatment of MS

Mood Disorders. What Are Mood Disorders? Unipolar vs. Bipolar

Depression Treatment Guide

Pragmatic Evidence Based Review Depression in moderate to severe TBI

Reversibility of Acute Demyelinating Lesions in relapsingremitting

Under the Start Your Search Now box, you may search by author, title and key words.

DEPRESSION IN NEUROLOGICAL DISORDERS: PARKINSON S DISEASE, MULTIPLE SCLEROSIS, AND STROKE

ADHD. & Coexisting Disorders in Children

The neuropsychiatry of multiple sclerosis

Treatments for Major Depression. Drug Treatments The two (2) classes of drugs that are typical antidepressants are:

Geriatric Mood and Anxiety Disorders: 5 Things you need to know about Treating Depression in the Elderly

ENTITLEMENT ELIGIBILITY GUIDELINE

Health Information Sheet

CNS Vital Signs Advancing Multiple Sclerosis Care

Depression in the Elderly: Recognition, Diagnosis, and Treatment

Ontario Reimburses CIS Indication for REBIF, a First-Line Treatment for Multiple Sclerosis

Clinical Bulletin. Individuals with multiple sclerosis (MS) can experience episodes of uncontrollable laughing and/

Overview, Epidemiology, and the DSM-5 Criteria for Gambling Disorder

0 Major Depression (>5), Minor Depression (2)

PCORE Depression Post Survey

Sleep Medicine and Psychiatry. Roobal Sekhon, D.O.

How to Recognize Depression and Its Related Mood and Emotional Disorders

Chapter Fourteen. Emotion, Reward, Aggression, and Stress

Paraplegia Depression, Disease and Disability: Application to Patients with Traumatic Spinal Cord Injury

Some helpful reminders on depression in children and young people. Maria Moldavsky Consultant Child and Adolescent Psychiatrist

THE DEPRESSION RESEARCH CLINIC Department of Psychiatry and Behavioral Sciences Stanford University, School of Medicine

Relapsing-remitting multiple sclerosis Ambulatory with or without aid

Depression in Long-Term Care

Disclosures. Consultant and Speaker for Biogen Idec, TEVA Neuroscience, EMD Serrono, Mallinckrodt, Novartis, Genzyme, Accorda Therapeutics

Accommodation and Compliance Series. Employees with Bipolar Disorder

SLEEP DISTURBANCE AND PSYCHIATRIC DISORDERS

Revised 7/05. Copyright 2005 St. Jude Children's Research Hospital Page 1 of 6

Wellness for People with MS: What do we know about Diet, Exercise and Mood And what do we still need to learn? March 2015

A Manic Episode is defined by a distinct period during which there is an abnormally and persistently elevated, expansive, or irritable mood.

Ronald G. Riechers, II, M.D. Medical Director, Polytrauma Team Cleveland VAMC Assistant Professor Department of Neurology Case Western Reserve

Anxiety and depression appropriate terms for cancer survivorship research?

The Relationship Between Anhedonia & Low Mood

Neuropharmacology II Antidepressants and Sedatives

See also for an online treatment course.

Sheep Brain Dissection

CLS 306 Men and Women s Health Research Paper. Is testosterone therapy a safe and effective approach to treating major depression in adult males?

A blood sample will be collected annually for up to 2 years for JCV antibody testing.

Memory, Behaviour, Emotional and Personality Changes after a Brain Injury

Treatment of Functional Neurological Disorders in Children and Adolescents

HOW RESEARCH INFLUENCES MS CARE TODAY? Patient Perspective Kimberly Haddock

Preventing Dementia: The Depression-Diabetes Nexus

Health on the Homefront: PTSD, Its Clinical Description, Treatment and Underlying Pathophysiology

Chapter end Name Period Date. MULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question.

MRI in Differential Diagnosis

HOW TO HELP HURTING PEOPLE (YOURSELF AND OTHERS)

Sex Differences in Profiles & Outcomes of Patients with Traumatic Brain Injury in an Inpatient Rehabilitation Sample

Amphetamines Addiction

Transcription:

Depression in MS: Is brain imaging helpful? Anthony Feinstein Professor, Department of Psychiatry Sunnybrook Health Sciences Centre & the University of Toronto Disclosures MS Society of Canada Canadian Institute of Health Research Biogen Teva, Merck-Serono, Novartis 1

Aims To appreciate the structural brain changes that can occur in depressed MS patients. To understand some of the functional brain changes linked to alteragtions in mood. To appreciate how the structural brain changes linked to depression differ from those seen in pseudobulbar affect Is brain imaging helpful in assessing depression in MS? 2

MRI: lesion change over time MRI with Gd every two weeks 6 months of scanning > 90 new lesions Little change in physical disability 5 secs = 1 week in the patient s life Acknowledgement: Prof. W. I. McDonald et al: Institute of Neurology, Queen Square Major Depression Prevalence lifetime prevalence in patients attending MS clinics approaches 50% However, prevalence is also raised in a community based sample. In a study of 115,071 Canadians, the 12 month prevalence of depression in MS patients exceeded that in healthy subjects (odds ratio: 3.4) In subjects ages 18-45 years, the 12 month prevalence was 25.7%. Rates increased in relation to other neurological disorders. 3

Major Depression Diagnostic criteria Five or more of the following during the same two week period: Depressed mood most of the day Markedly diminished interest or pleasure in all activities Appetite change with significant weight loss, or weight gain Insomnia or hypersomnia nearly every day Psychomotor agitation or retardation (observable by others) Fatigue or loss of energy nearly every day Feelings of worthlessness, excessive, inappropriate guilt Diminished ability to think or concentrate Recurrent thoughts of death Rating scales 4

Etiology of depression MS, depression and brain imaging 5

Figure 1 Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis. Pujol, J; Bello, J; Deus, J; Marti-Vilalta, J; Capdevila, A Neurology. 49(4):1105-1110, October 1997. Figure 1. Sagittal reformatted images (left in A, B, and C) showing the level and extent of the three different white matter regions considered in the axial analysis (basal [A], periventricular [B], and lateral [C]), and representative proton density axial images (right in A, B, and C) on which lesion measurements were performed. 1997 American Academy of Neurology. Published by LWW_American Academy of Neurology. 2 Figure 3 Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis. Pujol, J; Bello, J; Deus, J; Marti-Vilalta, J; Capdevila, A Neurology. 49(4):1105-1110, October 1997. Figure 3. Plot of Beck scores with coronal lesion areas of the left arcuate fasciculus region. Although the relationship was significant (r = 0.43, p = 0.001), high depression scores were registered in patients with no lesions in this region. 1997 American Academy of Neurology. Published by LWW_American Academy of Neurology. 2 6

Figure 4 Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis. Pujol, J; Bello, J; Deus, J; Marti-Vilalta, J; Capdevila, A Neurology. 49(4):1105-1110, October 1997. Figure 4. (A-F) Representative coronal inversion-recovery images of the six patients with the highest lesion scores of the left arcuate fasciculus region. Note that the bulk of the left arcuate fasciculus was substantially damaged in each case (arrow). L = left; R = right; IP = inferoposterior; IA = inferoanterior. 1997 American Academy of Neurology. Published by LWW_American Academy of Neurology. 2 MS, Depression and MRI changes 7

MS, Depression, lesion segmentation 8

MS, Depression, brain parcellation MS, Depression, diffusion tensor imaging 9

MS, Depression, lesions, atrophy, DTI MS, Depression and Diffusion Tensor Imaging Imaging predictors of depression MRI variables Percentage variance Lesions + atrophy 23.7% Lesions + atrophy + regional DTI indices (MD of NAGM and FA of NAWM) Lesions + atrophy + regional DTI indices (MD of NAGM and FA of NAWM + MD of right inferior frontal lesions) 35.1% 43.6% 10

The importance of the hippocampus Smaller Cornu Ammonis 2 3/Dentate Gyrus Volumes and Elevated Cortisol in Multiple Sclerosis Patients with Depressive Symptoms Gold et al, Biological Psychiatry 2010, 68, 553-9 11

Hypothalamic pituitary adrenal axis dysregulation in patients with comorbid relapsing remitting multiple sclerosis (RRMS) and major depressive disorder (MDD). Gold S M et al. J Neurol Neurosurg Psychiatry 2011;82:814-818 2011 by BMJ Publishing Group Ltd From: Mood Disorders and Dysfunction of the Hypothalamic-Pituitary-Adrenal Axis in Multiple Sclerosis: Association With Cerebral Inflammation Arch Neurol. 1998;55(1):66-72. doi:10.1001/archneur.55.1.66 Figure Legend: Mean±SEM scores on depression and anxiety scales for patients with multiple sclerosis (MS) with and without gadoliniumenhancing MS plaques. HRSD indicates Hamilton Rating Scale for Depression; SDS, Zung Self-Reporting Depression Scale; HRSA, Hamilton Rating Scale for Anxiety; and SAS, Zung Self-Reporting Anxiety Scale. Asterisk indicates P<.05; dagger, P<.01. Copyright 2012 American Medical Association. All rights reserved. 12

From: Mood Disorders and Dysfunction of the Hypothalamic-Pituitary-Adrenal Axis in Multiple Sclerosis: Association With Cerebral Inflammation Arch Neurol. 1998;55(1):66-72. doi:10.1001/archneur.55.1.66 Figure Legend: Mean±SEM serum levels of cortisol in patients with multiple sclerosis (MS) with and without gadolinium enhancement of MS plaques. Copyright 2012 American Medical Association. All rights reserved. Processing emotions in MS (patients without Major Depression and PBA excluded) Passamonti, L. et al. Brain 2009 0:awp095v1-95; doi:10.1093/brain/awp095 13

MS, Depression and brain imaging: summary Psychosocial causes of depression Bruce Frederick Cummings From the journal: June 15, 1917. I sit all day in my chair, moving 8 feet to my bed at night, and 8 feet from it to my chair in the morning and wait. The assignment is certain. From the journal: October 3, 1918. I am grateful to-day for some happy hours plucked triumphantly from under the very nose of Fate, and spent in the warm sun in the garden... A Lark sang...i sat by some Michaelmas Daisies and watched the Bees, Flies and Butterflies 14

Depression Psychosocial etiology Uncertainty (Lynch et al, 2001) Inadequate coping strategies (Mohr et al, 1997; Pakenham et al, 1997; Aikens et al, 1997; Jean et al, 1997; Pakenham 1999) Helplessness (Shnek et al, 1997; Patten et al, 2002; van der Werf, 2003) Poor social relationships (Maybury and Brewin, 1984) Loss of recreational activities (Voss et al 2002) High levels of stress (Patten et al, 2000) Fatigue (Lobentanz et al, 2004) Treating Major Depression: Medication Only Two RCTs Desipramine (tricyclic antidepressant) Paroxetine (SSRI) Medication effective Side effects troubling: anticholinergic problems Dry mouth Constipation Sedation Blurred vision Sexual difficulties 15

Stress management 24 weeks of treatment Less Gd+ lesions Less cumulative lesion load Effects not sustained beyond 24 weeks No clinical benefits, including mood MRI can predict response to depression treatment 16

Pathological laughing and crying Pathological laughing and crying (Pseudobulbar affect) Crying without sadness Laughter without happiness (mirth) Up to 10% of MS patients affected to various degrees 17

Pseudobulbar affect in MS: an MRI study Two groups of MS subjects PBA versus normal mood/affect change (n=14 for each group). All underwent neurological examination, cognitive testing (BRNB) and detailed MRI scanning Ghaffar et al. (2008) J. Neurology PBA associated with more lesions in the following areas: Region Sig. Global lesion volume T2.001 Brain stem T1.003 Medial inferior frontal L T2.004 Medial inferior frontal R T2.002 Medial superior frontal R T2.008 Inferior parietal L T2.000 Inferior parietal R T2.001 18

MRI regions Pseudobulbar Affect: Associated With Lesions at Various Locations Motor cortex Anterior association cortex Orbitofrontal cortex Posterior association cortex Facial muscles Pons Medulla To respiratory muscles 19

Major Depression and Pathological Laughing and Crying: Comparison of MRI variance Major Depression 40% Pathological laughing and crying ~ 75% Pseudobulbar affect R : low dose amitriptyline SSRI levodopa and amantadine Neudexta (dextromethorphan/quinidine) Response to treatment in PBA = 48 72 hours Response to treatment in major depression = 10 14 days 20

Treatment of PBA Is brain imaging helpful in assessing depression in MS? 21

Acknowledgments MS Society of Canada Canadian Institute of Health Research Bennis Pavisian Jordan Ellis Blair Audet Kris Romero Brad McIntosh Richard Staines Paul O Connor Liesley Lee 22